본문 바로가기
KERD
논문KCI 등재

Personalization of Repetitive Transcranial Magnetic Stimulation for the Treatment of Major Depressive Disorder According to the Existing Psychiatric Comorbidity

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

초록

Repetitive transcranial magnetic stimulation (rTMS) and intermittent theta-burst stimulation (iTBS) are evidenced-based treatments for patients with major depressive disorder (MDD) who fail to respond to standard first-line therapies. However, although various TMS protocols have been proven to be clinically effective, the response rate varies across clinical applications due to the heterogeneity of real-world psychiatric comorbidities, such as generalized anxiety disorder, posttraumatic stress disorder, panic disorder, or substance use disorder, which are often observed in patients with MDD. Therefore, individualized treatment approaches are important to increase treatment response by assigning a given patient to the most optimal TMS treatment protocol based on his or her individual profile. This literature review summarizes different rTMS or TBS protocols that have been applied in researches investigating MDD patients with certain psychiatric comorbidities and discusses biomarkers that may be used to predict rTMS treatment response. Furthermore, we highlight the need for the validation of neuroimaging and electrophysiological biomarkers associated with rTMS treatment responses. Finally, we discuss on which directions future efforts should focus for developing the personalization of the treatment of depression with rTMS or iTBS.

Abstract

Repetitive transcranial magnetic stimulation (rTMS) and intermittent theta-burst stimulation (iTBS) are evidenced-based treatments for patients with major depressive disorder (MDD) who fail to respond to standard first-line therapies. However, although various TMS protocols have been proven to be clinically effective, the response rate varies across clinical applications due to the heterogeneity of real-world psychiatric comorbidities, such as generalized anxiety disorder, posttraumatic stress disorder, panic disorder, or substance use disorder, which are often observed in patients with MDD. Therefore, individualized treatment approaches are important to increase treatment response by assigning a given patient to the most optimal TMS treatment protocol based on his or her individual profile. This literature review summarizes different rTMS or TBS protocols that have been applied in researches investigating MDD patients with certain psychiatric comorbidities and discusses biomarkers that may be used to predict rTMS treatment response. Furthermore, we highlight the need for the validation of neuroimaging and electrophysiological biomarkers associated with rTMS treatment responses. Finally, we discuss on which directions future efforts should focus for developing the personalization of the treatment of depression with rTMS or iTBS.

참고문헌 (107)

  1. Milev RV, "Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 4. Neurostimulation treatments", Can J Psychiatry, 61, pp.561~575 (2016)
  2. Perera T, "The clinical TMS society consensus review and treatment recommendations for TMS therapy for major depressive disorder", Brain Stimul, 9, pp.336~346 (2016)
  3. Li CT, "Prefrontal glucose metabolism in medication-resistant major depression", Br J Psychiatry, 206, pp.316~323 (2015)
  4. George MS, "Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder : a sham-controlled randomized trial", Arch Gen Psychiatry, 67, pp.507~516 (2010)
  5. O’Reardon JP, "Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression : a multisite randomized controlled trial", Biol Psychiatry, 62, pp.1208~1216 (2007)
  6. Lefaucheur JP, "Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation(rTMS) : an update(2014-2018)", Clin Neurophysiol, 131, pp.474~528 (2020)
  7. McClintock SM, "Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation(rTMS)in the treatment of depression", J Clin Psychiatry, 79, pp.16~ (2018)
  8. Trevizol AP, "Predictors of remission after repetitive transcranial magnetic stimulation for the treatment of major depressive disorder : an analysis from the randomised non-inferiority THREE-D trial", EClinicalMedicine, 22, pp.100349~ (2020)
  9. Grimm S, "Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment : an fMRI study in severe major depressive disorder", Biol Psychiatry, 63, pp.369~376 (2008)
  10. Wassermann EM, "Therapeutic application of repetitive transcranial magnetic stimulation : a review", Clin Neurophysiol, 112, pp.1367~1377 (2001)
  11. Chen J, "Left versus right repetitive transcranial magnetic stimulation in treating major depression : a meta-analysis of randomised controlled trials", Psychiatry Res, 210, pp.1260~1264 (2013)
  12. Lefaucheur JP, "Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation(rTMS)", Clin Neurophysiol, 125, pp.2150~2206 (2014)
  13. Fitzgerald PB, "A randomized trial of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in treatment-resistant major depression", Psychol Med, 41, pp.1187~1196 (2011)
  14. Brunoni AR, "Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes : a systematic review with network meta-analysis", JAMA Psychiatry, 74, pp.143~152 (2017)
  15. Li CT, "Efficacy of prefrontal theta-burst stimulation in refractory depression: a randomized sham-controlled study", Brain, 137(Pt 7), pp.2088~2098 (2014)
  16. Chou PH, "Antidepressant efficacy and immune effects of bilateral theta burst stimulation monotherapy in major depression : a randomized, double-blind, sham-controlled study", Brain Behav Immun, 88, pp.144~150 (2020)
  17. Cao X, "Response and remission rates following high-frequency vs. low-frequency repetitive transcranial magnetic stimulation (rTMS) over right DLPFC for treating major depressive disorder (MDD): a meta-analysis of randomized, double-blind trials", Front Psychiatry, 9, pp.413~ (2018)
  18. Feifel D, "Network meta-analysis in mental health research", JAMA Psychiatry, 74, pp.850~851 (2017)
  19. Roth Y, "Network meta-analysis in mental health research", JAMA Psychiatry, 74, pp.851~ (2017)
  20. Berlim MT, "Efficacy and acceptability of high frequency repetitive transcranial magnetic stimulation(rTMS)versus electroconvulsive therapy(ECT)for major depression : a systematic review and meta-analysis of randomized trials", Depress Anxiety, 30, pp.614~623 (2013)
  21. Murphy JA, "Prevalence and correlates of the proposed DSM-5 diagnosis of Chronic Depressive Disorder", J Affect Disord, 139, pp.172~180 (2012)
  22. Rush AJ, "Comorbid psychiatric disorders in depressed outpatients : demographic and clinical features", J Affect Disord, 87, pp.43~55 (2005)
  23. Rodrigues PA, "Transcranial magnetic stimulation for the treatment of anxiety disorder", Neuropsychiatr Dis Treat, 15, pp.2743~2761 (2019)
  24. Balderston NL, "Mechanistic link between right prefrontal cortical activity and anxious arousal revealed using transcranial magnetic stimulation in healthy subjects", Neuropsychopharmacology, 45, pp.694~702 (2020)
  25. White D, "Repetitive transcranial magnetic stimulation for treatment of major depressive disorder with comorbid generalized anxiety disorder", Ann Clin Psychiatry, 27, pp.192~196 (2015)
  26. Clarke E, "Efficacy of repetitive transcranial magnetic stimulation in the treatment of depression with comorbid anxiety disorders", J Affect Disord, 252, pp.435~439 (2019)
  27. Mantovani A, "Randomized sham controlled trial of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid major depression", J Affect Disord, 144, pp.153~159 (2013)
  28. Rao S, "Anxious depression : clinical features and treatment", Curr Psychiatry Rep, 11, pp.429~436 (2009)
  29. Fava M, "Difference in treatment outcome in outpatients with anxious versus nonanxious depression : a STAR*D report", Am J Psychiatry, 165, pp.342~351 (2008)
  30. Diefenbach GJ, "Treating anxious depression using repetitive transcranial magnetic stimulation", J Affect Disord, 151, pp.365~368 (2013)
  31. Chen L, "Is rTMS effective for anxiety symptoms in major depressive disorder? An efficacy analysis comparing left-sided high-frequency, right-sided low-frequency, and sequential bilateral rTMS protocols", Depress Anxiety, 36, pp.723~731 (2019)
  32. Kessler RC, "Posttraumatic stress disorder in the National Comorbidity Survey", Arch Gen Psychiatry, 52, pp.1048~1060 (1995)
  33. Rytwinski NK, "The co-occurrence of major depressive disorder among individuals with posttraumatic stress disorder : a meta-analysis", J Trauma Stress, 26, pp.299~309 (2013)
  34. Bernardy NC, "Psychopharmacological strategies in the management of posttraumatic stress disorder (PTSD): what have we learned?", Curr Psychiatry Rep, 17, pp.564~ (2015)
  35. Green BL, "Impact of PTSD comorbidity on one-year outcomes in a depression trial", J Clin Psychol, 62, pp.815~835 (2006)
  36. Post LM, "Understanding the relationship between co-occurring PTSD and MDD : symptom severity and affect", J Anxiety Disord, 25, pp.1123~1130 (2011)
  37. Cirillo P, "Transcranial magnetic stimulation in anxiety and trauma-related disorders : a systematic review and meta-analysis", Brain Behav, 9, pp.e01284~ (2019)
  38. Hernandez MJ, "Impact of comorbid PTSD on outcome of repetitive transcranial magnetic stimulation(TMS)for veterans with depression", J Clin Psychiatry, 81, pp.19~ (2020)
  39. Rosenberg PB, "Repetitive transcranial magnetic stimulation treatment of comorbid posttraumatic stress disorder and major depression", J Neuropsychiatry Clin Neurosci, 14, pp.270~276 (2002)
  40. Osuch EA, "Repetitive TMS combined with exposure therapy for PTSD : a preliminary study", J Anxiety Disord, 23, pp.54~59 (2009)
  41. Philip NS, "5-Hz transcranial magnetic stimulation for comorbid posttraumatic stress disorder and major depression", J Trauma Stress, 29, pp.93~96 (2016)
  42. Carpenter LL, "5 Hz repetitive transcranial magnetic stimulation for posttraumatic stress disorder comorbid with major depressive disorder", J Affect Disord, 235, pp.414~420 (2018)
  43. Cohen JE, "Emotional brain rhythms and their impairment in post-traumatic patients", Hum Brain Mapp, 34, pp.1344~1356 (2013)
  44. Boggio PS, "Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder", J Clin Psychiatry, 71, pp.992~999 (2010)
  45. Cohen H, "Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder : a double-blind, placebo-controlled study", Am J Psychiatry, 161, pp.515~524 (2004)
  46. Philip NS, "Theta-burst transcranial magnetic stimulation for posttraumatic stress disorder", Am J Psychiatry, 176, pp.939~948 (2019)
  47. Pettorruso M, "rTMS reduces psychopathological burden and cocaine consumption in treatmentseeking subjects with cocaine use disorder : an open label, feasibility study", Front Psychiatry, 10, pp.621~ (2019)
  48. Zhang JJQ, "Effects of repetitive transcranial magnetic stimulation(rTMS)on craving and substance consumption in patients with substance dependence : a systematic review and meta-analysis", Addiction, 114, pp.2137~2149 (2019)
  49. Balconi M, "Reward-system effect(BAS rating), left hemispheric"unbalance"(alpha band oscillations)and decisional impairments in drug addiction", Addict Behav, 39, pp.1026~1032 (2014)
  50. Eldreth DA, "Abnormal brain activity in prefrontal brain regions in abstinent marijuana users", Neuroimage, 23, pp.914~920 (2004)
  51. Feffer K, "Early symptom improvement at 10 sessions as a predictor of rTMS treatment outcome in major depression", Brain Stimul, 11, pp.181~189 (2018)
  52. Sujita Kumar Kar, "Predictors of Response to Repetitive Transcranial Magnetic Stimulation in Depression: A Review of Recent Updates", Clinical Psychopharmacology and Neuroscience, 17(1), pp.25~33 (2019), 대한정신약물학회[DOI]
  53. Li CT, "Antidepressant efficacy of prolonged intermittent theta burst stimulation monotherapy for recurrent depression and comparison of methods for coil positioning : a randomized, double-blind, sham-controlled study", Biol Psychiatry, 87, pp.443~450 (2020)
  54. Blumberger DM, "Unilateral and bilateral MRI-targeted repetitive transcranial magnetic stimulation for treatment-resistant depression : a randomized controlled study", J Psychiatry Neurosci, 41, pp.E58~ (2016)
  55. Mutz J, "Comparative efficacy and acceptability of nonsurgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis", BMJ, 364, pp.l1079~ (2019)
  56. Huang YZ, "Theta burst stimulation of the human motor cortex", Neuron, 45, pp.201~206 (2005)
  57. Rachid F, "Safety and efficacy of theta-burst stimulation in the treatment of psychiatric disorders : a review of the literature", J Nerv Ment Dis, 205, pp.823~839 (2017)
  58. Wischnewski M, "Efficacy and time course of theta burst stimulation in healthy humans", Brain Stimul, 8, pp.685~692 (2015)
  59. Li CT, "Effects of prefrontal theta-burst stimulation on brain function in treatment-resistant depression : a randomized sham-controlled neuroimaging study", Brain Stimul, 11, pp.1054~1062 (2018)
  60. Trevizol AP, "An update on repetitive transcranial magnetic stimulation for the treatment of major depressive disorder", Clin Pharmacol Ther, 106, pp.747~762 (2019)
  61. Prasser J, "Bilateral prefrontal rTMS and theta burst TMS as an add-on treatment for depression : a randomized placebo controlled trial", World J Biol Psychiatry, 16, pp.57~65 (2015)
  62. Plewnia C, "Treatment of major depression with bilateral theta burst stimulation : a randomized controlled pilot trial", J Affect Disord, 156, pp.219~223 (2014)
  63. Chistyakov AV, "Preliminary assessment of the therapeutic efficacy of continuous theta-burst magnetic stimulation(cTBS)in major depression : a double-blind shamcontrolled study", J Affect Disord, 170, pp.225~229 (2015)
  64. Duprat R, "Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: a fast road to remission?", J Affect Disord, 200, pp.6~14 (2016)
  65. Blumberger DM, "Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression(THREE-D) : a randomised noninferiority trial", Lancet, 391, pp.1683~1692 (2018)
  66. Hanlon CA, "Left frontal pole theta burst stimulation decreases orbitofrontal and insula activity in cocaine users and alcohol users", Drug Alcohol Depend, 178, pp.310~317 (2017)
  67. Petrosino NJ, "One-year clinical outcomes following theta burst stimulation for post-traumatic stress disorder", Neuropsychopharmacology, 45, pp.940~946 (2020)
  68. Teneback CC, "Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily eft prefrontal TMS", J Neuropsychiatry Clin Neurosci, 11, pp.426~435 (1999)
  69. Speer AM, "Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients", Biol Psychiatry, 48, pp.1133~1141 (2000)
  70. Paillère Martinot ML, "Baseline brain metabolism in resistant depression and response to transcranial magnetic stimulation", Neuropsychopharmacology, 36, pp.2710~2719 (2011)
  71. Hernández-Ribas R, "Identifying brain imaging correlates of clinical response to repetitive transcranial magnetic stimulation(rTMS)in major depression", Brain Stimul, 6, pp.54~61 (2013)
  72. Baeken C, "HF-rTMS treatment in medication-resistant melancholic depression : results from 18FDG-PET brain imaging", CNS Spectr, 14, pp.439~448 (2009)
  73. Baeken C, "The impact of accelerated HF-rTMS on the subgenual anterior cingulate cortex in refractory unipolar major depression : insights from 18FDG PET brain imaging", Brain Stimul, 8, pp.808~815 (2015)
  74. Kito S, "Regional cerebral blood flow changes after low-frequency transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in treatment-resistant depression", Neuropsychobiology, 58, pp.29~36 (2008)
  75. Kito S, "Neuroanatomical correlates of therapeutic efficacy of low-frequency right prefrontal transcranial magnetic stimulation in treatment-resistant depression", Psychiatry Clin Neurosci, 65, pp.175~182 (2011)
  76. Liston C, "Default mode network mechanisms of transcranial magnetic stimulation in depression", Biol Psychiatry, 76, pp.517~526 (2014)
  77. Fox MD, "Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate", Biol Psychiatry, 72, pp.595~603 (2012)
  78. Fox MD, "Identification of reproducible individualized targets for treatment of depression with TMS based on intrinsic connectivity", Neuroimage, 66, pp.151~160 (2013)
  79. Li CT, "Cognition-modulated frontal activity in prediction and augmentation of antidepressant efficacy : a randomized controlled pilot study", Cereb Cortex, 26, pp.202~210 (2016)
  80. Chou PH, "The potential role of functional near-infrared spectroscopy as clinical biomarkers in schizophrenia", Curr Pharm Des, 26, pp.201~217 (2020)
  81. Chou PH, "Reduced language lateralization in first episode schizophrenia : a near infrared spectroscopy study", Prog Neuropsychopharmacol Biol Psychiatry, 78, pp.96~104 (2017)
  82. Chou PH, "Reduced frontal activity during a verbal fluency test in fibromyalgia : a near-infrared spectroscopy study", J Clin Neurosci, 50, pp.35~40 (2018)
  83. Sato H, "A NIRS-fMRI investigation of prefrontal cortex activity during a working memory task", Neuroimage, 83, pp.158~173 (2013)
  84. Chou PH, "Perceived occupational stress is associated with decreased cortical activity of the prefrontal cortex : a multichannel near-infrared spectroscopy study", Sci Rep, 6, pp.39089~ (2016)
  85. Chou PH, "Duration of untreated psychosis and brain function during verbal fluency testing in first-episode schizophrenia : a near-infrared spectroscopy study", Sci Rep, 5, pp.18069~ (2015)
  86. Chou PH, "Distinct effects of duration of untreated psychosis on brain cortical activities in different treatment phases of schizophrenia : a multi-channel near-infrared spectroscopy study", Prog Neuropsychopharmacol Biol Psychiatry, 49, pp.63~69 (2014)
  87. Eschweiler GW, "Left prefrontal activation predicts therapeutic effects of repetitive transcranial magnetic stimulation(rTMS)in major depression", Psychiatry Res, 99, pp.161~172 (2000)
  88. Shinba T, "Increase of frontal cerebral blood volume during transcranial magnetic stimulation in depression is related to treatment effectiveness : a pilot study with near-infrared spectroscopy", Psychiatry Clin Neurosci, 72, pp.602~610 (2018)
  89. Arns M, "Neurophysiological predictors of non-response to rTMS in depression", Brain Stimul, 5, pp.569~576 (2012)
  90. Krepel N, "Non-replication of neurophysiological predictors of non-response to rTMS in depression and neurophysiological data-sharing proposal", Brain Stimul, 11, pp.639~641 (2018)
  91. Price GW, "Appraisal of sessional EEG features as a correlate of clinical changes in an rTMS treatment of depression", Clin EEG Neurosci, 39, pp.131~138 (2008)
  92. Micoulaud-Franchi JA, "Parieto-temporal alpha EEG band power at baseline as a predictor of antidepressant treatment response with repetitive transcranial magnetic stimulation : a preliminary study", J Affect Disord, 137, pp.156~160 (2012)
  93. Narushima K, "Subgenual cingulate theta activity predicts treatment response of repetitive transcranial magnetic stimulation in participants with vascular depression", J Neuropsychiatry Clin Neurosci, 22, pp.75~84 (2010)
  94. Leuchter AF, "Cordance : a new method for assessment of cerebral perfusion and metabolism using quantitative electroencephalography", Neuroimage, 1, pp.208~219 (1994)
  95. Bares M, "QEEG theta cordance in the prediction of treatment outcome to prefrontal repetitive transcranial magnetic stimulation or venlafaxine ER in patients with major depressive disorder", Clin EEG Neurosci, 46, pp.73~80 (2015)
  96. Hunter AM, "Change in quantitative EEG theta cordance as a potential predictor of repetitive transcranial magnetic stimulation clinical outcome in major depressive disorder", Clin EEG Neurosci, 49, pp.306~315 (2018)
  97. Turker Tekin Erguzel, "Neural Network Based Response Prediction of rTMS in Major Depressive Disorder Using QEEG Cordance", PSYCHIATRY INVESTIGATION, 12(1), pp.61~65 (2015), 대한신경정신의학회[DOI]
  98. Shalbaf R, "Non-linear entropy analysis in EEG to predict treatment response to repetitive transcranial magnetic stimulation in depression", Front Pharmacol, 9, pp.1188~ (2018)
  99. Isserles M, "Simple electroencephalographic treatment-emergent marker can predict repetitive transcranial magnetic stimulation antidepressant response-a feasibility study", J ECT, 34, pp.274~282 (2018)
  100. Widge AS, "Electroencephalographic biomarkers for treatment response prediction in major depressive illness : a meta-analysis", Am J Psychiatry, 176, pp.44~56 (2019)
  101. Koenig J, "Depression and resting state heart rate variability in children and adolescents-a systematic review and meta-analysis", Clin Psychol Rev, 46, pp.136~150 (2016)
  102. Licht CM, "Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety(NESDA)", Arch Gen Psychiatry, 65, pp.1358~1367 (2008)
  103. Kemp AH, "Impact of depression and antidepressant treatment on heart rate variability : a review and meta-analysis", Biol Psychiatry, 67, pp.1067~1074 (2010)
  104. Makovac E, "A meta-analysis of non-invasive brain stimulation and autonomic functioning:Implications for brain-heart pathways to cardiovascular disease", Neurosci Biobehav Rev, 74(Pt B), pp.330~341 (2017)
  105. Udupa K, "Modulation of cardiac autonomic functions in patients with major depression treated with repetitive transcranial magnetic stimulation", J Affect Disord, 104, pp.231~236 (2007)
  106. Iseger TA, "Neuro-Cardiac-Guided TMS(NCG-TMS) : probing DLPFCsgACC-vagus nerve connectivity using heart rate-first results", Brain Stimul, 10, pp.1006~1008 (2017)
  107. Cipriani A, "Conceptual and technical challenges in network meta-analysis", Ann Intern Med, 159, pp.130~137 (2013)

이 간행물의 다른 논문 (19건)